Enhancing Medication Adherence for Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by rapid muscle degeneration, primarily affecting boys. Effective management of DMD necessitates strict adherence to complex medication regimens, which can be challenging. Perigon Pharmacy addresses these challenges through a comprehensive support system designed to enhance medication adherence and improve patient outcomes. Medication adherence is vital for DMD patients as it …

Perigon Pharmacy 360 Named Exclusive Specialty Provider for Generic Deflazacort Oral Suspension

PITTSBURGH, June 6, 2024 /PRNewswire/ – Perigon Pharmacy 360, a leading provider of specialized pharmacy services for rare and complex conditions, proudly announces its exclusive partnership as the designated specialty pharmacy for the newly released generic deflazacort oral suspension, for the treatment of Duchenne muscular dystrophy (DMD). This partnership marks a significant stride in accessible healthcare solutions while reinforcing Perigon …

Perigon Pharmacy 360 Joins Paratek’s Limited Distribution Network for NUZYRA®

Coraopolis, PA, November 15, 2023 – Perigon Pharmacy 360 (Perigon), a leading precision digital pharmacy, proudly announces its selection to join Paratek Pharmaceuticals’ (Paratek) Limited Distribution Network for their breakthrough drug, NUZYRA®. This strategic partnership seamlessly aligns with Perigon’s mission to provide innovative healthcare solutions to patients in need. NUZYRA (omadacycline) is a novel antibiotic with both once-daily oral and …

Tris Pharma Partners with Perigon Pharmacy 360 to Enhance Access to DYANAVEL® XR Tablets for the Treatment of Attention Deficit Hyperactivity Disorder

— National direct-to-patient program allows patients and caregivers to obtain DYANAVEL XR extended-release tablet prescriptions from digital pharmacy — MONMOUTH JUNCTION, NJ, October 30, 2023 – Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced a new partnership with Perigon Pharmacy 360, a full-service, specialty digital pharmacy, to …

Reflections from Asembia 2023

Considered one of the most anticipated events in the healthcare industry, Asembia’s Specialty Pharmacy Summit draws thousands of the nation’s leading pharmacy and pharmaceutical industry decision-makers to its annual conference. Each year, stakeholders from around the country gather to share new ideas, understand challenges, and define the future of healthcare with meaningful, innovative solutions for patients. And this year’s AXS23 …

Enhanced Pharmacist Communication Drives Enhanced Patient Outcomes

We are commonly told in relationships that communication is key. And while we usually apply this logic to a loved-one, it should be used in many aspects of our lives, especially in healthcare. Effective communication with patients is the building block to successful treatment outcomes. Evidence shows that 40% to 80% of medical information that health care professionals communicate to …

Perigon Pharmacy 360 And Spencer Health Solutions Announce Collaboration to Bring Innovative, In-Home Engagement Technology to High-Touch Pharmacy Care

Partnership increases access to sponsored spencer SmartHub™ programs for patients with complex, chronic conditions. Perigon Pharmacy 360 (Perigon) announced today that it has signed a collaboration agreement with Spencer Health Solutions, Inc. (SHS). This agreement will expand the reach of SHS’ innovative, in-home digital medication adherence-promoting technology with the help of Perigon’s existing end-to-end, specialty pharmacy support programs for patients …

The Importance of Monitoring Blood Pressure

As mentioned in our LinkedIn Post, there is a huge need to identify high-risk patients who need hypertension management. In one retrospective cohort study published by the American Journal of Managed Care, the impact of a pharmacist intervention on blood pressure control was studied. The objective of the study was to evaluate the impact of the chronic medication optimization pharmacist …

Huntington’s Disease

Huntington’s disease is a progressive brain disease that currently has no cure. Huntington’s disease (HD) is a genetic disease that is caused by an error in the DNA at a specific gene. As a person ages, this error starts to affect the brain greatly in areas that control mood, behavior, and movement.  DNA is made up of a collection of …

AIDS Awareness Month

December is World AIDS Awareness Month and we are using this day to reflect upon our worldwide response to the HIV/AIDS epidemic. This year marks 40 years since the first cases of what would become known as AIDS were reported. We are honoring the more than 36 million people worldwide, including 700,000 in the United States, who lost their lives …